Rossari Biotech Limited
Rossari Biotech Limited manufactures and sells specialty chemicals in India and internationally. It offers soap and detergents; inks, paints, and coatings; ceramics and tiles; pulp and papers; cement; performance additives; and water treatment solutions. The company also provides textile specialty chemicals, such as cotton, polyester, acrylic, wool, silk, nylon, functional finishes, denim, printi… Read more
Rossari Biotech Limited (ROSSARI) - Total Assets
Latest total assets as of September 2025: ₹20.88 Billion INR
Based on the latest financial reports, Rossari Biotech Limited (ROSSARI) holds total assets worth ₹20.88 Billion INR as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Rossari Biotech Limited - Total Assets Trend (2017–2025)
This chart illustrates how Rossari Biotech Limited’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Rossari Biotech Limited - Asset Composition Analysis
Current Asset Composition (March 2025)
Rossari Biotech Limited's total assets of ₹20.88 Billion consist of 55.0% current assets and 45.0% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₹0.00 | 3.0% |
| Accounts Receivable | ₹4.76 Billion | 25.1% |
| Inventory | ₹3.55 Billion | 18.7% |
| Property, Plant & Equipment | ₹0.00 | 0.0% |
| Intangible Assets | ₹1.26 Billion | 6.7% |
| Goodwill | ₹1.19 Billion | 6.3% |
Asset Composition Trend (2017–2025)
This chart illustrates how Rossari Biotech Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Rossari Biotech Limited's current assets represent 55.0% of total assets in 2025, a decrease from 64.5% in 2017.
- Cash Position: Cash and equivalents constituted 3.0% of total assets in 2025, up from 1.6% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 12.0% of total assets, an increase from 0.0% in 2017.
- Asset Diversification: The largest asset category is accounts receivable at 25.1% of total assets.
Rossari Biotech Limited Competitors by Total Assets
Key competitors of Rossari Biotech Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Akzo Nobel N.V
OTCQX:AKZOF
|
USA | $13.95 Billion |
|
YeSUN Tech Co.Ltd.
KQ:250930
|
Korea | ₩51.65 Billion |
|
Hangzhou Flariant Co Ltd
SHG:605566
|
China | CN¥2.55 Billion |
|
Samhwa Paint
KO:000390
|
Korea | ₩617.09 Billion |
|
DL Holdings CO. LTD.
KO:000210
|
Korea | ₩12.05 Trillion |
|
Norooholdings
KO:000320
|
Korea | ₩1.26 Trillion |
|
Noroo Holdings Co Ltd
KO:000325
|
Korea | ₩1.26 Trillion |
|
Chongqing Sanxia Paints Co Ltd
SHE:000565
|
China | CN¥1.65 Billion |
Rossari Biotech Limited - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Rossari Biotech Limited generates 1.10x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, Rossari Biotech Limited generates $7.19 in net profit.
Rossari Biotech Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.73 | 2.08 | 2.57 |
| Quick Ratio | 1.14 | 1.35 | 1.88 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ₹4.69 Billion | ₹ 4.87 Billion | ₹ 1.90 Billion |
Rossari Biotech Limited - Advanced Valuation Insights
This section examines the relationship between Rossari Biotech Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.30 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 20.6% |
| Total Assets | ₹18.96 Billion |
| Market Capitalization | $86.31 Million USD |
Valuation Analysis
Below Book Valuation: The market values Rossari Biotech Limited's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Rossari Biotech Limited's assets grew by 20.6% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Rossari Biotech Limited (2017–2025)
The table below shows the annual total assets of Rossari Biotech Limited from 2017 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | ₹18.96 Billion | +20.61% |
| 2024-03-31 | ₹15.72 Billion | +14.96% |
| 2023-03-31 | ₹13.68 Billion | +8.82% |
| 2022-03-31 | ₹12.57 Billion | +123.88% |
| 2021-03-31 | ₹5.61 Billion | +19.05% |
| 2020-03-31 | ₹4.72 Billion | +88.72% |
| 2019-03-31 | ₹2.50 Billion | +51.47% |
| 2018-03-31 | ₹1.65 Billion | +26.02% |
| 2017-03-31 | ₹1.31 Billion | -- |